Biohaven Pharmaceutical Hold
13F holders, Q2 2024 (June 30)3holders +1
1new positions
0sold out
$34.71avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Biohaven Pharmaceutical Hold in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Knoll Capital Management, LLC ($24.7M), Birchview Capital, LP ($256K) and Itau Unibanco Holding S.A. ($3K).
- Company
- Biohaven Pharmaceutical Hold
- CUSIP
- G11196105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 220,088 shares bought, net +220,088 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Knoll Capital Management, LLC | 16.62% | Add +44.9% | 710,422 | $24.7M |
| Birchview Capital, LP | 0.24% | No change | 7,365 | $256K |
| Itau Unibanco Holding S.A. | 0.00% | New | 88 | $3K |
"% of holder's portfolio" is BIOHAVEN PHARMACEUTICAL HOLD's weight in each manager's 13F, not the share of Biohaven Pharmaceutical Hold the manager owns.